Arsène MEKINIAN
Impact in
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Rheumatology 71
- Systemic Lupus Erythematosus Research 54
-
- Systemic Sclerosis and Related Diseases 45
- Co-authors
- O. Fain (162 shared papers)Michaël Soussan (24 shared papers)Eric HACHULLA (21 shared papers)Jaume Alijotas‐Reig (13 shared papers)Pascale Nicaise‐Roland (14 shared papers)David Launay (15 shared papers)Lionel Carbillon (16 shared papers)Noémie Abisror (32 shared papers)
In The Last Decade
Arsène MEKINIAN
396 papers receiving 11.8k citations
Arsène MEKINIAN's Hit Papers
Peers
Comparison fields: 5 of 92
- Rheumatology 1.5k
- Infectious Diseases 1.3k
- Pulmonary and Respiratory Medicine 2.0k
- Hematology 864
- Pathology and Forensic Medicine 752
Countries citing papers authored by Arsène MEKINIAN
This map shows the geographic impact of Arsène MEKINIAN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arsène MEKINIAN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arsène MEKINIAN more than expected).
Fields of papers citing papers by Arsène MEKINIAN
This network shows the impact of papers produced by Arsène MEKINIAN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arsène MEKINIAN. The network helps show where Arsène MEKINIAN may publish in the future.
Co-authors
The 25 scholars most cited alongside Arsène MEKINIAN, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 437 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 599 | |
| 2 | 2018 | 332 | |
| 3 | Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients* Hit paper breakdown → | 2021 | 295 |
| 4 | Autoimmune haemolytic anaemia associated with COVID‐19 infection Hit paper breakdown → | 2020 | 246 |
| 5 | 2020 | 242 | |
| 6 | 2021 | 232 | |
| 7 | 2015 | 225 | |
| 8 | 2017 | 220 | |
| 9 | 2021 | 214 | |
| 10 | 2015 | 182 | |
| 11 | 2020 | 180 | |
| 12 | 2017 | 175 | |
| 13 | 2020 | 174 | |
| 14 | 2017 | 168 | |
| 15 | Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study Hit paper breakdown → | 2022 | 167 |
| 16 | 2019 | 159 | |
| 17 | 2015 | 146 | |
| 18 | 2015 | 143 | |
| 19 | 2014 | 138 | |
| 20 | 2019 | 133 |
About Arsène MEKINIAN
Arsène MEKINIAN is a scholar working on Rheumatology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hematology and Immunology, having authored 437 papers that have together received 12.1k indexed citations. Recurring topics across this work include Vasculitis and related conditions (70 papers), Systemic Lupus Erythematosus Research (54 papers), Systemic Sclerosis and Related Diseases (45 papers), Acute Myeloid Leukemia Research (19 papers), COVID-19 Clinical Research Studies (15 papers), Reproductive System and Pregnancy (13 papers), Salivary Gland Disorders and Functions (12 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). The work is most often cited by research in Rheumatology (1.5k citations), Infectious Diseases (1.3k citations), Pulmonary and Respiratory Medicine (2.0k citations), Hematology (864 citations) and Pathology and Forensic Medicine (752 citations). Arsène MEKINIAN has collaborated with scholars based in France, Italy and Spain. Frequent co-authors include O. Fain, Michaël Soussan, Eric HACHULLA, Jaume Alijotas‐Reig, Pascale Nicaise‐Roland, David Launay, Lionel Carbillon, Noémie Abisror, Gabriel Pop and Patrick Nicolas. Their work appears in journals such as Lara D. Veeken, Autoimmunity Reviews, Annals of the Rheumatic Diseases, Journal of Autoimmunity and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.